跳到正文
原文
Nature 健康护理主题·· 2026-10-16AI 评分55

非重症社区获得性肺炎使用全身性糖皮质激素与30天死亡率无显著关联:一项倾向评分匹配研究

Use of corticosteroids in nonsevere community acquired pneumonia a propensity score matching study

AI 导读

一项哥伦比亚多中心回顾性队列研究纳入2821例非重症社区获得性肺炎成人患者,倾向评分匹配后,全身性糖皮质激素使用与30天死亡率无显著关联。匹配后估计的绝对风险差为3.1个百分点(95% CI −0.040至0.102;p=0.389),按激素类型、剂量和疗程分组也未观察到显著生存差异。

正文

Scientific Reports (2026) Cite this article

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Abstract

Community acquired pneumonia (CAP) is a major cause of morbidity and mortality. Although corticosteroids have shown benefits in severe CAP, their usefulness in non severe cases remains uncertain. This study assessed the association between systemic corticosteroids and 30-day mortality in adults hospitalized with non severe CAP. A multicenter retrospective cohort was conducted including adults hospitalized with non severe CAP between 2010 and 2020 in Colombia. Patients whose index episode was nosocomial pneumonia, as well as those with immunosuppression or connective tissue disease and those requiring vasopressors or mechanical ventilation, were excluded. Propensity score matching (1:1) was applied, and survival was analyzed using Kaplan Meier curves, including evaluations by corticosteroid type, dose and duration. A total of 2821 patients were included, with an overall 30-day mortality of 7.6%. Of these, 507 patients (18.0%) received corticosteroids, with a mortality rate of 10.4%, whereas the remaining 2314 patients who did not receive corticosteroids had a mortality rate of 7.0%. The propensity score-matched cohort included 448 patients (224 in each group). In the matched analysis, 30-day mortality was 14.3% among patients who received corticosteroids compared with 10.7% among those who did not. Before matching, patients treated with corticosteroids were older and had a higher burden of respiratory symptoms and comorbidities. After matching, baseline characteristics were well balanced between groups. After propensity score matching, no significant association was observed between corticosteroid use and 30-day mortality (average treatment effect on the treated [ATET] 0.031, 95% CI − 0.040 to 0.102; p = 0.389). The ATET estimates the absolute risk difference; an ATET of 0.031 corresponds to an absolute difference of 3.1 percentage points in 30-day mortality. Additionally, no significant differences in survival were found according to corticosteroid type, dose, or treatment duration. In adults with non-severe CAP, the use of systemic corticosteroids did not demonstrate a statistically significant difference in 30-day mortality.

Acknowledgements

The authors are most thankful for the Universidad de La Sabana.

Funding

This work was supported by a grant from Universidad de La Sabana (Grant No. MEDESP-47-2026) under the project titled “Uso de Corticoide en Neumonía Leve: un Estudio de Propensity Score Matching.”

Author information

Authors and Affiliations

  1. School of Medicine, Universidad de La Sabana, Campus del Puente del Común, Km 7 Autopista Norte de Bogotá, Chía, 250001, Cundinamarca, Colombia

    Juan Sebastian Hernández Puentes, Alirio Rodrigo Bastidas Goyes, Laura F. Sánchez, Eduardo Andres Tuta Quintero, Juan Diego Castro Córdoba, Lina María López Nuñez, Laura F. Alzate, Sarah C. Bayona, Yuliana V. Rincón, Alejandra Charry, Gabriela Salcedo, Nicole Tovar, Luisa Fernánda Parra, Luisa Fernánda Martínez, David Castro & Ingrid S. Sanchez

  2. Clinical Medicine Applied Research Group, Universidad de La Sabana, Campus del Puente del Común, Km 7 Autopista Norte de Bogotá, Chía, 250001, Cundinamarca, Colombia

    Alirio Rodrigo Bastidas Goyes

  3. Department of Internal Medicine, Universidad de La Sabana, Campus del Puente del Común, Km 7 Autopista Norte de Bogotá, Chía, 250001, Cundinamarca, Colombia

    Alirio Rodrigo Bastidas Goyes, Eduardo Andres Tuta Quintero, Luisa Fernánda Parra & Luisa Fernánda Martínez

Authors

  1. Juan Sebastian Hernández Puentes
  2. Alirio Rodrigo Bastidas Goyes
  3. Laura F. Sánchez
  4. Eduardo Andres Tuta Quintero
  5. Juan Diego Castro Córdoba
  6. Lina María López Nuñez
  7. Laura F. Alzate
  8. Sarah C. Bayona
  9. Yuliana V. Rincón
  10. Alejandra Charry
  11. Gabriela Salcedo
  12. Nicole Tovar
  13. Luisa Fernánda Parra
  14. Luisa Fernánda Martínez
  15. David Castro
  16. Ingrid S. Sanchez

Corresponding author

Correspondence to Alirio Rodrigo Bastidas Goyes.

Ethics declarations

Competing interests

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Consent to participate

This is a retrospective database analysis study and the consent to participate is waived by the institutional review board.

Ethical approval

The study was conducted in accordance with the principles of the current Helsinki Declaration, as well as local, regional, and international regulations pertaining to clinical research, including Colombian Law on Biomedical Research. Ethical approval was obtained from the Medical Ethics Committee of the Clínica Universidad de La Sabana, Chia, Colombia (approval number: 20220102 Date: 17/01/2022), Approval from the ethics committee waived the requirement for informed consent, in accordance with current regulations for retrospective studies.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Appendix

Appendix

See Table 6.

Table 6 Sensitivity analyses using different causal inference methods to estimate the average treatment effect on the treated (ATET) for 30-day mortality.

Full size table

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hernández Puentes, J.S., Bastidas Goyes, A.R., Sánchez, L.F. et al. Use of corticosteroids in nonsevere community acquired pneumonia a propensity score matching study. Sci Rep (2026). https://doi.org/10.1038/s41598-026-73712-3

Download citation

  • Received: 03 April 2026

  • Accepted: 24 September 2026

  • Published: 16 October 2026

  • DOI: https://doi.org/10.1038/s41598-026-73712-3

Keywords

来源:Nature 健康护理主题 · nature.com